The U.S. FDA is currently gathering information on products from Indian spice makers MDH and Everest after Hong Kong halted sales of some of their products for allegedly containing high levels of a cancer-causing pesticide.
An FDA representative said, “We are aware of the reports & are currently collecting more details about the situation.”
Hong Kong has stopped sales of three MDH spice mixes and one Everest spice mix for fish curries. Singapore issued a recall of the Everest spice mix, alleging that it consists of high quantities of ethylene oxide, which is unsafe for human ingestion and poses a cancer risk with long-term exposure.
Continue Exploring: Singapore recalls Everest’s Fish Curry Masala due to high pesticide levels
MDH and Everest did not respond to requests for comment.
MDH and Everest spices, highly regarded in India and distributed across Europe, Asia, and North America, are now under scrutiny by Indian regulators for compliance with quality standards, following actions taken by Hong Kong and Singapore.
Continue Exploring: FSSAI launches quality checks on MDH and Everest spice mixes following reports of high ethylene oxide levels
